Jennifer M. Scarff, Ph.D.
Affiliations: | 2011 | University of Virginia, Charlottesville, VA |
Area:
Microbiology BiologyGoogle:
"Jennifer Scarff"Parents
Sign in to add mentorJoanna B. Goldberg | grad student | 2011 | UVA | |
(Efficacy of a Pseudomonas aeruginosa Vaccine in Immunocompromised Mice.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Moustafa DA, DiGiandomenico A, Raghuram V, et al. (2023) Efficacy of a serogroup O9 vaccine. Infection and Immunity. e0024723 |
Moustafa DA, DiGiandomenico A, Raghuram V, et al. (2023) Efficacy of a Serogroup O9 Vaccine. Biorxiv : the Preprint Server For Biology |
Scarff JM, Seldina YI, Vergis JM, et al. (2018) Expression and contribution to virulence of each polysaccharide capsule of Bacillus cereus strain G9241. Plos One. 13: e0202701 |
Scarff JM, Raynor MJ, Seldina YI, et al. (2016) The Roles of AtxA Orthologs in Virulence of Anthrax-like Bacillus cereus G9241. Molecular Microbiology |
Moustafa DA, Scarff JM, Garcia PP, et al. (2015) Recombinant Salmonella Expressing Burkholderia mallei LPS O Antigen Provides Protection in a Murine Model of Melioidosis and Glanders. Plos One. 10: e0132032 |
Moustafa DA, Scarff JM, Garcia PP, et al. (2015) Opsonophagocytosis killing of B. thailandensis. Plos One |
Moustafa DA, Scarff JM, Garcia PP, et al. (2015) Survival rates and bacterial loads in organs of intranasally immunized BALB/c mice after intranasal challenge with B . thailandensis (5 x 10 6 CFU). Plos One |
Moustafa DA, Scarff JM, Garcia PP, et al. (2015) Serum antibody response of BALB/c mice following intranasal immunization with S . enterica serovar Typhimurium SL3261 expressing B . mallei O antigen. Plos One |
Moustafa DA, Scarff JM, Garcia PP, et al. (2015) Analysis of LPS expression and immunoreactivity. Plos One |
Scarff JM, Goldberg JB. (2008) Vaccination against Pseudomonas aeruginosa pneumonia in immunocompromised mice. Clinical and Vaccine Immunology : Cvi. 15: 367-75 |